Skip to main content

Advertisement

Table 3 Cost per QALY from societal perspective

From: Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

% getting % of meningitis cases with long-term sequelae
Anaphalaxis From IAP 22.5% 35% 47.5%* 60%
0% 68,536 36,609 5,558 cs
0.001% 69,883 37,336 5,749 cs
0.004% 74,252 39,690 6,155 cs
0.022%* 117,993 63,025 10,641 cs
0.040% 279,253 145,536 25,857 cs
  1. * baseline rate.
  2. cs denotes cost-saving.